ARROWHEAD PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 83.64 million shares for the 12-month period ending 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2018-12-11
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 88.11M shares, a 17.82% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-06-30 was 87.63M shares, a 17.20% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-03-31 was 84.08M shares, a 12.67% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-12-31 was 74.83M shares, a 4.74% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 83.64M shares, a 13.18% increase from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 73.90M shares, a 21.04% increase from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 61.05M shares, a 6.44% increase from fiscal 2015.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 57.36M shares, a 22.21% increase from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2018-09-30 | 88.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | 87.87M shares derived: average of 2 quarters · filed 2018-12-11 | 86.61M shares derived: average of 3 quarters · filed 2018-12-11 | 83.64M shares 10-K · filed 2018-12-11 |
| 2018-06-30 | 87.63M shares 10-Q · filed 2018-08-07 | 85.86M shares derived: average of 2 quarters · filed 2018-08-07 | 82.15M shares 10-Q · filed 2018-08-07 | 80.33M shares derived: average of 4 quarters · filed 2018-12-11 |
| 2018-03-31 | 84.08M shares 10-Q · filed 2018-05-08 | 79.41M shares 10-Q · filed 2018-05-08 | 77.90M shares derived: average of 3 quarters · filed 2018-12-11 | 77.12M shares derived: average of 4 quarters · filed 2018-12-11 |
| 2017-12-31 | 74.83M shares 10-Q · filed 2018-02-09 | 74.81M shares derived: average of 2 quarters · filed 2018-12-11 | 74.80M shares derived: average of 3 quarters · filed 2018-12-11 | 74.75M shares derived: average of 4 quarters · filed 2018-12-11 |
| 2017-09-30 | 74.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | 74.78M shares derived: average of 2 quarters · filed 2018-12-11 | 74.73M shares derived: average of 3 quarters · filed 2018-12-11 | 73.90M shares 10-K · filed 2018-12-11 |
| 2017-06-30 | 74.77M shares 10-Q · filed 2018-08-07 | 74.70M shares derived: average of 2 quarters · filed 2018-08-07 | 73.60M shares 10-Q · filed 2018-08-07 | 71.44M shares derived: average of 4 quarters · filed 2018-12-11 |
| 2017-03-31 | 74.63M shares 10-Q · filed 2018-05-08 | 73.02M shares 10-Q · filed 2018-05-08 | 70.33M shares derived: average of 3 quarters · filed 2018-12-11 | 67.74M shares derived: average of 4 quarters · filed 2018-12-11 |
| 2016-12-31 | 71.44M shares 10-Q · filed 2018-02-09 | 68.18M shares derived: average of 2 quarters · filed 2018-12-11 | 65.44M shares derived: average of 3 quarters · filed 2018-12-11 | 64.03M shares derived: average of 4 quarters · filed 2018-12-11 |
| 2016-09-30 | 64.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | 62.44M shares derived: average of 2 quarters · filed 2018-12-11 | 61.55M shares derived: average of 3 quarters · filed 2018-12-11 | 61.05M shares 10-K · filed 2018-12-11 |
| 2016-06-30 | 59.97M shares 10-Q · filed 2017-08-03 | 59.87M shares derived: average of 2 quarters · filed 2017-08-03 | 59.76M shares 10-Q · filed 2017-08-03 | 59.71M shares derived: average of 4 quarters · filed 2017-12-12 |
| 2016-03-31 | 59.78M shares 10-Q · filed 2017-05-03 | 59.66M shares 10-Q · filed 2017-05-03 | 59.62M shares derived: average of 3 quarters · filed 2017-12-12 | 59.59M shares derived: average of 4 quarters · filed 2017-12-12 |
| 2015-12-31 | 59.55M shares 10-Q · filed 2017-02-06 | 59.54M shares derived: average of 2 quarters · filed 2017-12-12 | 59.53M shares derived: average of 3 quarters · filed 2017-12-12 | 58.58M shares derived: average of 4 quarters · filed 2017-12-12 |
| 2015-09-30 | 59.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | 59.52M shares derived: average of 2 quarters · filed 2017-12-12 | 58.25M shares derived: average of 3 quarters · filed 2017-12-12 | 57.36M shares 10-K · filed 2017-12-12 |
| 2015-06-30 | 59.49M shares 10-Q · filed 2016-08-09 | 57.61M shares derived: average of 2 quarters · filed 2016-08-09 | 56.63M shares 10-Q · filed 2016-08-09 | 55.99M shares derived: average of 4 quarters · filed 2016-12-14 |
| 2015-03-31 | 55.72M shares 10-Q · filed 2016-05-10 | 55.20M shares 10-Q · filed 2016-05-10 | 54.82M shares derived: average of 3 quarters · filed 2016-12-14 | 54.10M shares derived: average of 4 quarters · filed 2016-12-14 |
| 2014-12-31 | 54.69M shares 10-Q · filed 2016-02-09 | 54.36M shares derived: average of 2 quarters · filed 2016-12-14 | 53.55M shares derived: average of 3 quarters · filed 2016-12-14 | 51.25M shares derived: average of 4 quarters · filed 2016-12-14 |
| 2014-09-30 | 54.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 52.98M shares derived: average of 2 quarters · filed 2016-12-14 | 50.10M shares derived: average of 3 quarters · filed 2016-12-14 | 46.93M shares 10-K · filed 2016-12-14 |
| 2014-06-30 | 51.93M shares 10-Q · filed 2015-08-04 | 48.13M shares derived: average of 2 quarters · filed 2015-08-04 | 44.57M shares 10-Q · filed 2015-08-04 | 43.33M shares derived: average of 4 quarters · filed 2015-12-14 |
| 2014-03-31 | 44.32M shares 10-Q · filed 2015-05-11 | 40.94M shares 10-Q · filed 2015-05-11 | 40.46M shares derived: average of 3 quarters · filed 2015-12-14 | 36.88M shares derived: average of 4 quarters · filed 2015-12-14 |
| 2013-12-31 | 37.74M shares 10-Q · filed 2015-02-09 | 38.54M shares derived: average of 2 quarters · filed 2015-12-14 | 34.40M shares derived: average of 3 quarters · filed 2015-12-14 | 29.92M shares derived: average of 4 quarters · filed 2015-12-14 |
| 2013-09-30 | 39.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | 32.73M shares derived: average of 2 quarters · filed 2015-12-14 | 27.31M shares derived: average of 3 quarters · filed 2015-12-14 | 24.00M shares 10-K · filed 2015-12-14 |
| 2013-06-30 | 26.13M shares 10-Q · filed 2014-08-12 | 21.30M shares derived: average of 2 quarters · filed 2014-08-12 | 18.89M shares 10-Q · filed 2014-08-12 | 17.30M shares derived: average of 4 quarters · filed 2014-11-25 |
| 2013-03-31 | 16.46M shares 10-Q · filed 2014-05-06 | 15.27M shares 10-Q · filed 2014-05-06 | 14.36M shares derived: average of 3 quarters · filed 2014-11-25 | 13.58M shares derived: average of 4 quarters · filed 2014-11-25 |
| 2012-12-31 | 14.11M shares 10-Q · filed 2014-02-04 | 13.31M shares derived: average of 2 quarters · filed 2014-11-25 | 12.62M shares derived: average of 3 quarters · filed 2014-11-25 | 12.13M shares derived: average of 4 quarters · filed 2014-11-25 |
| 2012-09-30 | 12.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | 11.87M shares derived: average of 2 quarters · filed 2014-11-25 | 11.47M shares derived: average of 3 quarters · filed 2014-11-25 | 11.13M shares 10-K · filed 2014-11-25 |
| 2012-06-30 | 11.24M shares 10-Q · filed 2013-08-07 | 10.95M shares derived: average of 2 quarters · filed 2013-08-07 | 10.67M shares 10-Q · filed 2013-08-07 | |
| 2012-03-31 | 10.66M shares 10-Q · filed 2013-05-09 | 10.39M shares 10-Q · filed 2013-05-09 | ||
| 2011-12-31 | 10.12M shares 10-Q · filed 2013-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |